Andrew Fein
Stock Analyst at HC Wainwright & Co.
(3.14)
# 1,190
Out of 4,732 analysts
552
Total ratings
40.48%
Success rate
2.47%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGON CG Oncology | Reiterates: Buy | $75 | $29.08 | +157.91% | 1 | Jan 13, 2025 | |
| DYN Dyne Therapeutics | Reiterates: Buy | $55 | $14.13 | +289.24% | 9 | Jan 13, 2025 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $30 → $35 | $22.78 | +53.64% | 13 | Jan 10, 2025 | |
| KMDA Kamada | Reiterates: Buy | $11 | $7.16 | +53.63% | 9 | Jan 10, 2025 | |
| PVLA Palvella Therapeutics | Reiterates: Buy | $38 | $13.18 | +188.32% | 3 | Jan 10, 2025 | |
| RNA Avidity Biosciences | Reiterates: Buy | $72 | $28.92 | +148.96% | 2 | Jan 10, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 | $9.36 | +273.93% | 11 | Jan 8, 2025 | |
| DNLI Denali Therapeutics | Maintains: Buy | $90 → $87 | $21.93 | +296.72% | 20 | Jan 7, 2025 | |
| GPCR Structure Therapeutics | Reiterates: Buy | $80 | $27.06 | +195.64% | 3 | Dec 20, 2024 | |
| PRTA Prothena Corporation | Reiterates: Buy | $84 → $48 | $13.77 | +248.58% | 14 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $600 → $535 | $422.00 | +26.78% | 24 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 → $13 | $4.31 | +201.62% | 13 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.20 | +614.29% | 14 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $190 | $143.26 | +32.63% | 15 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 → $47 | $10.86 | +332.78% | 12 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.37 | +321.94% | 11 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.40 | +525.00% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $87 | $18.05 | +381.99% | 15 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $4.55 | +405.49% | 13 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $8.30 | +140.96% | 13 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $3.60 | +233.33% | 18 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $39.45 | +115.46% | 15 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.01 | +497.01% | 15 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.24 | +792.86% | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.68 | +497.01% | 13 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $135 | $110.05 | +22.67% | 16 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.07 | +647.66% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $12.89 | +124.98% | 11 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $3.96 | +1.01% | 16 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $6 | $2.93 | +104.78% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $10.99 | +100.18% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.65 | +809.09% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $1 | $0.22 | +355.79% | 16 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $1.93 | +780.83% | 11 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $2.30 | +1,030.43% | 9 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $1.71 | +1,946.78% | 8 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $17.57 | +53.67% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $72.51 | +24.12% | 11 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $300 | $140.55 | +113.45% | 18 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $425 | $358.93 | +18.41% | 13 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $35 | $4.47 | +683.87% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $11.92 | +571.14% | 5 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.73 | +362.43% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.45 | +302.68% | 8 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $40.61 | +13.27% | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $3.94 | +77.66% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.11 | +63.67% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.87 | +1,294.70% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.57 | +26,078.01% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $3 | $0.56 | +437.63% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.84 | +209.92% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $3.85 | +939.31% | 3 | Mar 16, 2022 |
CG Oncology
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $29.08
Upside: +157.91%
Dyne Therapeutics
Jan 13, 2025
Reiterates: Buy
Price Target: $55
Current: $14.13
Upside: +289.24%
Catalyst Pharmaceuticals
Jan 10, 2025
Maintains: Buy
Price Target: $30 → $35
Current: $22.78
Upside: +53.64%
Kamada
Jan 10, 2025
Reiterates: Buy
Price Target: $11
Current: $7.16
Upside: +53.63%
Palvella Therapeutics
Jan 10, 2025
Reiterates: Buy
Price Target: $38
Current: $13.18
Upside: +188.32%
Avidity Biosciences
Jan 10, 2025
Reiterates: Buy
Price Target: $72
Current: $28.92
Upside: +148.96%
Stoke Therapeutics
Jan 8, 2025
Maintains: Buy
Price Target: $35
Current: $9.36
Upside: +273.93%
Denali Therapeutics
Jan 7, 2025
Maintains: Buy
Price Target: $90 → $87
Current: $21.93
Upside: +296.72%
Structure Therapeutics
Dec 20, 2024
Reiterates: Buy
Price Target: $80
Current: $27.06
Upside: +195.64%
Prothena Corporation
Dec 20, 2024
Reiterates: Buy
Price Target: $84 → $48
Current: $13.77
Upside: +248.58%
Dec 20, 2024
Maintains: Buy
Price Target: $600 → $535
Current: $422.00
Upside: +26.78%
Dec 17, 2024
Reiterates: Buy
Price Target: $20 → $13
Current: $4.31
Upside: +201.62%
Dec 17, 2024
Reiterates: Buy
Price Target: $30
Current: $4.20
Upside: +614.29%
Dec 16, 2024
Reiterates: Buy
Price Target: $190
Current: $143.26
Upside: +32.63%
Dec 13, 2024
Reiterates: Buy
Price Target: $100 → $47
Current: $10.86
Upside: +332.78%
Dec 12, 2024
Reiterates: Buy
Price Target: $10
Current: $2.37
Upside: +321.94%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.40
Upside: +525.00%
Dec 11, 2024
Reiterates: Buy
Price Target: $87
Current: $18.05
Upside: +381.99%
Dec 6, 2024
Reiterates: Buy
Price Target: $23
Current: $4.55
Upside: +405.49%
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $8.30
Upside: +140.96%
Dec 5, 2024
Reiterates: Buy
Price Target: $12
Current: $3.60
Upside: +233.33%
Dec 5, 2024
Reiterates: Buy
Price Target: $85
Current: $39.45
Upside: +115.46%
Nov 18, 2024
Reiterates: Buy
Price Target: $12
Current: $2.01
Upside: +497.01%
Nov 15, 2024
Reiterates: Buy
Price Target: $20
Current: $2.24
Upside: +792.86%
Nov 15, 2024
Reiterates: Buy
Price Target: $16
Current: $2.68
Upside: +497.01%
Nov 15, 2024
Reiterates: Buy
Price Target: $135
Current: $110.05
Upside: +22.67%
Nov 15, 2024
Reiterates: Buy
Price Target: $8
Current: $1.07
Upside: +647.66%
Nov 14, 2024
Reiterates: Buy
Price Target: $29
Current: $12.89
Upside: +124.98%
Nov 14, 2024
Reiterates: Neutral
Price Target: $4
Current: $3.96
Upside: +1.01%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $2.93
Upside: +104.78%
Nov 13, 2024
Reiterates: Buy
Price Target: $22
Current: $10.99
Upside: +100.18%
Nov 13, 2024
Reiterates: Buy
Price Target: $15
Current: $1.65
Upside: +809.09%
Nov 13, 2024
Downgrades: Neutral
Price Target: $6 → $1
Current: $0.22
Upside: +355.79%
Nov 8, 2024
Reiterates: Buy
Price Target: $17
Current: $1.93
Upside: +780.83%
Nov 8, 2024
Reiterates: Buy
Price Target: $26
Current: $2.30
Upside: +1,030.43%
Nov 7, 2024
Reiterates: Buy
Price Target: $35
Current: $1.71
Upside: +1,946.78%
Nov 7, 2024
Reiterates: Buy
Price Target: $27
Current: $17.57
Upside: +53.67%
Nov 1, 2024
Reiterates: Buy
Price Target: $90
Current: $72.51
Upside: +24.12%
Oct 31, 2024
Reiterates: Buy
Price Target: $300
Current: $140.55
Upside: +113.45%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $425
Current: $358.93
Upside: +18.41%
Oct 24, 2024
Maintains: Buy
Price Target: $25 → $35
Current: $4.47
Upside: +683.87%
Sep 23, 2024
Reiterates: Buy
Price Target: $80
Current: $11.92
Upside: +571.14%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $1.73
Upside: +362.43%
Aug 6, 2024
Reiterates: Buy
Price Target: $30
Current: $7.45
Upside: +302.68%
Jun 17, 2024
Reiterates: Buy
Price Target: $46
Current: $40.61
Upside: +13.27%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $3.94
Upside: +77.66%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.11
Upside: +63.67%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.87
Upside: +1,294.70%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.57
Upside: +26,078.01%
May 5, 2022
Downgrades: Neutral
Price Target: $10 → $3
Current: $0.56
Upside: +437.63%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.84
Upside: +209.92%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $3.85
Upside: +939.31%